Followers | 8 |
Posts | 744 |
Boards Moderated | 0 |
Alias Born | 07/16/2006 |
Sunday, December 23, 2007 8:30:58 PM
SPNC pays SRDX royalties for use of lubricious coatings. I do not know the complete list of Spectranetics products that use SRDX technology, but I suspect that the CLiRpath catheters are included. CLiRpath catheters are used for vascular laser angioplasty when total obstructions in the thigh and leg are not crossable with a guidewire. The CLiRpath Turbo product line with lubricious coating was launched in the third quarter of 2006.
In FY 2006 SPNC paid SRDX $372,000 (per the SPNC FY 2006 10K filed 3/16/07). This is not of the same magnitude as the Cordis payments, but it is a tidy sum never the less. Particularly, since Spectronetics is growing rapidly. Last quarter the 36% increase in SPNC’s disposable product revenue (to $17.3M) was driven primarily by a 42% increase in atherectomy product sales (the sales I presume generate SRDX revenues).
As background.... SPNC develops, manufactures, markets and distributes single-use medical devices used with their proprietary excimer laser system. Current applications include 1) atherectomy, to remove arterial blockages in the peripheral and coronary vasculature, and 2) the removal of infected, defective, or abandoned cardiac lead wires from patients with pacemakers or implantable cardiac defibrillators, or ICDs. The disposable fiber-optic laser catheters contain small diameter, flexible optical fibers to access plaques and evenly distribute laser energy.
Recent SRDX News
- Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm • PR Newswire (US) • 06/17/2024 12:08:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/10/2024 08:57:37 PM
- Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. • Business Wire • 06/10/2024 11:00:00 AM
- Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. • PR Newswire (US) • 05/29/2024 10:36:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2024 12:04:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2024 11:28:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 11:27:01 AM
- Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million • Business Wire • 05/29/2024 11:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/24/2024 08:01:05 PM
- Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance • Business Wire • 05/01/2024 11:00:00 AM
- Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1 • Business Wire • 04/19/2024 11:00:00 AM
- Surmodics to Participate in Upcoming Investor Conferences in March and April • Business Wire • 02/27/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:22:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:18:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:16:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:12:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:08:12 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 04:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:27:42 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 02:53:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/01/2024 01:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 12:00:10 PM
- Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance • Business Wire • 02/01/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 09:29:09 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM